Orthopedic Practice Valuation: What Is an Orthopedic Group Worth?
A transaction-focused guide to orthopedic practice valuation, connecting operating evidence, buyer underwriting, transaction risk, and seller outcomes.
Behavioral Health Company Valuation: How Buyers Determine Enterprise Value
A buyer-led guide to behavioral health company valuation covering revenue quality, payer and authorization risk, census durability, clinician capacity, normalized EBITDA, compliance, valuation methods, lender underwriting, deal structure, and seller proceeds across mental health, ABA, autism services, pediatric therapy, I/DD, and substance use treatment.
Behavioral Health Valuation Multiples: EBITDA, Census, Payer Mix, and Buyer Demand
By George Barsom, JD, CM&AA®, CAIA® • Last updated: June 23, 2026 Updated for behavioral-health owners evaluating normalized EBITDA, revenue and census quality, payer and authorization exposure, clinician capacity, compliance, add-on versus platform positioning, financing capacity, deal structure, and seller proceeds across mental health, ABA, autism services, pediatric therapy, I/DD, substance use treatment, and related care models….
How to Sell a Behavioral Health Company: Valuation, Buyers, and Exit Planning
A seller-focused guide to selling a behavioral health company, including exit planning, valuation preparation, payer and clinician transferability, buyer selection, compliance and claims diligence, confidentiality, LOI comparison, transaction structure, transition planning, and seller proceeds.
How to Sell a Pharma Services Company: CRO, CDMO, and Life Sciences Exit Planning
A seller-focused guide to selling a CRO, CDMO, or broader pharma services company, including valuation preparation, buyer selection, diligence readiness, LOI comparison, confidentiality, transition planning, deal structure, and seller proceeds.
How to Sell a Home Health Agency: Valuation, Buyers, and Exit Planning
A seller-focused guide to selling a home health agency, including valuation preparation, buyer types, diligence readiness, LOI comparison, confidentiality, transition planning, deal structure, and seller proceeds.
Hospice M&A: Valuation, Buyer Demand, and Consolidation in End-of-Life Care
A hospice-specific M&A guide explaining how buyers underwrite hospice businesses, including census quality, length-of-stay distribution, live discharges, referral durability, compliance diligence, EBITDA, valuation multiples, deal structure, and seller proceeds.
How M&A Buyers Value Water & Wastewater Engineering Firms
A buyer-underwriting guide to how water and wastewater engineering firms are valued, including the specific revenue-quality, backlog, margin, concentration, and deal-structure factors that move enterprise value and EBITDA multiples in live transactions.
What M&A Buyers Look for in Water Engineering Firms
By George Barsom, JD, CM&AA®, CAIA® • Last updated: May 9, 2026 Updated for founders, operators, acquirers, and referral partners evaluating what M&A buyers look for in water and wastewater engineering firms. This guide focuses on buyer underwriting, diligence evidence, valuation support, and deal-structure implications across service mix, backlog quality, client concentration, margins, contract risk, working capital,…
Municipal vs. Industrial Water Engineering Firms: How M&A Buyers Compare Them
A deal-focused comparison of municipal and industrial water engineering firms that explains how contract structure, funding sources, backlog visibility, client concentration, and operating risk shape buyer underwriting, valuation, and transaction outcomes.
